Weight Loss Therapeutics Market, Global Outlook and Forecast 2022-2028

April 2022 | 108 pages | ID: WE54B369143DEN
Market Monitor Global

Abstracts

Currently, available weight loss mainly therapeutics works by appetite suppression, increasing body metabolism and interfering with the digestion and absorption patterns.

This report contains market size and forecasts of Weight Loss Therapeutics in Global, including the following market information:

Global Weight Loss Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Weight Loss Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Appetite Suppression Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Weight Loss Therapeutics include Abbott, Sanofi, Novo Nordisk, Arena Pharmaceuticals, Orexigen Therapeutics, Johnson & Johnson, Pfizer, Novartis AG and Biocon, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Weight Loss Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Weight Loss Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Weight Loss Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Appetite Suppression
• Increasing Body Metabolism
• Interfering with the Digestion Absorption Patterns

Global Weight Loss Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Weight Loss Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Specialized Clinics
• Retail Pharmacies
• Mail Order Pharmacies
• Others

Global Weight Loss Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Weight Loss Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Weight Loss Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Weight Loss Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Sanofi
• Novo Nordisk
• Arena Pharmaceuticals
• Orexigen Therapeutics
• Johnson & Johnson
• Pfizer
• Novartis AG
• Biocon
• VIVUS
• Eli Lilly
• Amgen
• Zafgen
• Roche
• Eisai

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Weight Loss Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Weight Loss Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL WEIGHT LOSS THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Weight Loss Therapeutics Market Size: 2021 VS 2028
2.2 Global Weight Loss Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Weight Loss Therapeutics Players in Global Market
3.2 Top Global Weight Loss Therapeutics Companies Ranked by Revenue
3.3 Global Weight Loss Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Weight Loss Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Weight Loss Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Weight Loss Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Weight Loss Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Weight Loss Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Weight Loss Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Appetite Suppression
  4.1.3 Increasing Body Metabolism
  4.1.4 Interfering with the Digestion Absorption Patterns
4.2 By Type - Global Weight Loss Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Weight Loss Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Weight Loss Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Weight Loss Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Weight Loss Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Specialized Clinics
  5.1.4 Retail Pharmacies
  5.1.5 Mail Order Pharmacies
  5.1.6 Others
5.2 By Application - Global Weight Loss Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Weight Loss Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Weight Loss Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Weight Loss Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Weight Loss Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Weight Loss Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Weight Loss Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Weight Loss Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Weight Loss Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Weight Loss Therapeutics Revenue, 2017-2028
  6.3.2 US Weight Loss Therapeutics Market Size, 2017-2028
  6.3.3 Canada Weight Loss Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Weight Loss Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Weight Loss Therapeutics Revenue, 2017-2028
  6.4.2 Germany Weight Loss Therapeutics Market Size, 2017-2028
  6.4.3 France Weight Loss Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Weight Loss Therapeutics Market Size, 2017-2028
  6.4.5 Italy Weight Loss Therapeutics Market Size, 2017-2028
  6.4.6 Russia Weight Loss Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Weight Loss Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Weight Loss Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Weight Loss Therapeutics Revenue, 2017-2028
  6.5.2 China Weight Loss Therapeutics Market Size, 2017-2028
  6.5.3 Japan Weight Loss Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Weight Loss Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Weight Loss Therapeutics Market Size, 2017-2028
  6.5.6 India Weight Loss Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Weight Loss Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Weight Loss Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Weight Loss Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Weight Loss Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Weight Loss Therapeutics Market Size, 2017-2028
  6.7.3 Israel Weight Loss Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Weight Loss Therapeutics Market Size, 2017-2028
  6.7.5 UAE Weight Loss Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Weight Loss Therapeutics Major Product Offerings
  7.1.4 Abbott Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Sanofi
  7.2.1 Sanofi Corporate Summary
  7.2.2 Sanofi Business Overview
  7.2.3 Sanofi Weight Loss Therapeutics Major Product Offerings
  7.2.4 Sanofi Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Sanofi Key News
7.3 Novo Nordisk
  7.3.1 Novo Nordisk Corporate Summary
  7.3.2 Novo Nordisk Business Overview
  7.3.3 Novo Nordisk Weight Loss Therapeutics Major Product Offerings
  7.3.4 Novo Nordisk Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Novo Nordisk Key News
7.4 Arena Pharmaceuticals
  7.4.1 Arena Pharmaceuticals Corporate Summary
  7.4.2 Arena Pharmaceuticals Business Overview
  7.4.3 Arena Pharmaceuticals Weight Loss Therapeutics Major Product Offerings
  7.4.4 Arena Pharmaceuticals Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Arena Pharmaceuticals Key News
7.5 Orexigen Therapeutics
  7.5.1 Orexigen Therapeutics Corporate Summary
  7.5.2 Orexigen Therapeutics Business Overview
  7.5.3 Orexigen Therapeutics Weight Loss Therapeutics Major Product Offerings
  7.5.4 Orexigen Therapeutics Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Orexigen Therapeutics Key News
7.6 Johnson & Johnson
  7.6.1 Johnson & Johnson Corporate Summary
  7.6.2 Johnson & Johnson Business Overview
  7.6.3 Johnson & Johnson Weight Loss Therapeutics Major Product Offerings
  7.6.4 Johnson & Johnson Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Johnson & Johnson Key News
7.7 Pfizer
  7.7.1 Pfizer Corporate Summary
  7.7.2 Pfizer Business Overview
  7.7.3 Pfizer Weight Loss Therapeutics Major Product Offerings
  7.7.4 Pfizer Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Pfizer Key News
7.8 Novartis AG
  7.8.1 Novartis AG Corporate Summary
  7.8.2 Novartis AG Business Overview
  7.8.3 Novartis AG Weight Loss Therapeutics Major Product Offerings
  7.8.4 Novartis AG Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Novartis AG Key News
7.9 Biocon
  7.9.1 Biocon Corporate Summary
  7.9.2 Biocon Business Overview
  7.9.3 Biocon Weight Loss Therapeutics Major Product Offerings
  7.9.4 Biocon Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Biocon Key News
7.10 VIVUS
  7.10.1 VIVUS Corporate Summary
  7.10.2 VIVUS Business Overview
  7.10.3 VIVUS Weight Loss Therapeutics Major Product Offerings
  7.10.4 VIVUS Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 VIVUS Key News
7.11 Eli Lilly
  7.11.1 Eli Lilly Corporate Summary
  7.11.2 Eli Lilly Business Overview
  7.11.3 Eli Lilly Weight Loss Therapeutics Major Product Offerings
  7.11.4 Eli Lilly Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Eli Lilly Key News
7.12 Amgen
  7.12.1 Amgen Corporate Summary
  7.12.2 Amgen Business Overview
  7.12.3 Amgen Weight Loss Therapeutics Major Product Offerings
  7.12.4 Amgen Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 Amgen Key News
7.13 Zafgen
  7.13.1 Zafgen Corporate Summary
  7.13.2 Zafgen Business Overview
  7.13.3 Zafgen Weight Loss Therapeutics Major Product Offerings
  7.13.4 Zafgen Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.13.5 Zafgen Key News
7.14 Roche
  7.14.1 Roche Corporate Summary
  7.14.2 Roche Business Overview
  7.14.3 Roche Weight Loss Therapeutics Major Product Offerings
  7.14.4 Roche Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.14.5 Roche Key News
7.15 Eisai
  7.15.1 Eisai Corporate Summary
  7.15.2 Eisai Business Overview
  7.15.3 Eisai Weight Loss Therapeutics Major Product Offerings
  7.15.4 Eisai Weight Loss Therapeutics Revenue in Global Market (2017-2022)
  7.15.5 Eisai Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Weight Loss Therapeutics Market Opportunities & Trends in Global Market
Table 2. Weight Loss Therapeutics Market Drivers in Global Market
Table 3. Weight Loss Therapeutics Market Restraints in Global Market
Table 4. Key Players of Weight Loss Therapeutics in Global Market
Table 5. Top Weight Loss Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Weight Loss Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Weight Loss Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Weight Loss Therapeutics Product Type
Table 9. List of Global Tier 1 Weight Loss Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Weight Loss Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Weight Loss Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Weight Loss Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Weight Loss Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Weight Loss Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Weight Loss Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Weight Loss Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Weight Loss Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Weight Loss Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Weight Loss Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Weight Loss Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Weight Loss Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Weight Loss Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Weight Loss Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Weight Loss Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Weight Loss Therapeutics Product Offerings
Table 32. Abbott Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Weight Loss Therapeutics Product Offerings
Table 35. Sanofi Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Novo Nordisk Corporate Summary
Table 37. Novo Nordisk Weight Loss Therapeutics Product Offerings
Table 38. Novo Nordisk Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Arena Pharmaceuticals Corporate Summary
Table 40. Arena Pharmaceuticals Weight Loss Therapeutics Product Offerings
Table 41. Arena Pharmaceuticals Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Orexigen Therapeutics Corporate Summary
Table 43. Orexigen Therapeutics Weight Loss Therapeutics Product Offerings
Table 44. Orexigen Therapeutics Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Weight Loss Therapeutics Product Offerings
Table 47. Johnson & Johnson Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Weight Loss Therapeutics Product Offerings
Table 50. Pfizer Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Novartis AG Corporate Summary
Table 52. Novartis AG Weight Loss Therapeutics Product Offerings
Table 53. Novartis AG Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Biocon Corporate Summary
Table 55. Biocon Weight Loss Therapeutics Product Offerings
Table 56. Biocon Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. VIVUS Corporate Summary
Table 58. VIVUS Weight Loss Therapeutics Product Offerings
Table 59. VIVUS Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Eli Lilly Corporate Summary
Table 61. Eli Lilly Weight Loss Therapeutics Product Offerings
Table 62. Eli Lilly Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Amgen Corporate Summary
Table 64. Amgen Weight Loss Therapeutics Product Offerings
Table 65. Amgen Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. Zafgen Corporate Summary
Table 67. Zafgen Weight Loss Therapeutics Product Offerings
Table 68. Zafgen Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)
Table 69. Roche Corporate Summary
Table 70. Roche Weight Loss Therapeutics Product Offerings
Table 71. Roche Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)
Table 72. Eisai Corporate Summary
Table 73. Eisai Weight Loss Therapeutics Product Offerings
Table 74. Eisai Weight Loss Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Weight Loss Therapeutics Segment by Type in 2021
Figure 2. Weight Loss Therapeutics Segment by Application in 2021
Figure 3. Global Weight Loss Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Weight Loss Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Weight Loss Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Weight Loss Therapeutics Revenue in 2021
Figure 8. By Type - Global Weight Loss Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Weight Loss Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Weight Loss Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Weight Loss Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Weight Loss Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Weight Loss Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Weight Loss Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Weight Loss Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Weight Loss Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novo Nordisk Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Arena Pharmaceuticals Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Orexigen Therapeutics Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson & Johnson Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis AG Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Biocon Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. VIVUS Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Eli Lilly Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Amgen Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Zafgen Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Roche Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Eisai Weight Loss Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)